DRU SAMUEL DACE, PH.D.

Carrollton, TX 75010

dru@dacescientific.com

www.dacescientific.com

www.linkedin.com/in/drudace

 

I am a skilled medical writer with a PhD, strong basic research background, and over 7 years of medical writing experience, all in the oncology space. I have experience in both the CME and promotional medical communications fields.

My focus is on producing high-quality work, meeting timelines, and creating trust with my clients by exceeding their expectations.                                                                                   

 

EMPLOYMENT HISTORY

 

2015-present              Dace Scientific Communications, LLC

                                    Principal, Freelance Medical Writer

 

2014-2015                   Vaniam Group, LLC

                                    Senior Director, Scientific Communications

 

2013-2014                   PhysiciansÕ Education Resource (PER)

                                    Director of Scientific Affairs

 

2009-2013                   inVentiv Medical Communications

Associate Scientific Director (2011-2013)

(Senior) Medical Writer (2009-2011)

             

2007-2009                   Washington University in St. Louis School of Medicine

Postdoctoral Research Associate, Department of Ophthalmology and Visual Sciences

                                     

EDUCATION

 

2001-2007                   Doctor of Philosophy (Ph.D.)

                                    University of Texas Southwestern Medical Center; Dallas, TX

                                    Immunology Graduate Program and Department of Ophthalmology

                                   

1999-2001                   Master of Science (M.S.)

                                    University of Central Arkansas; Conway, AR

                                    Department of Biology

 

1995-1999                   Bachelor of Science (B.S.)

                                    University of Arkansas; Fayetteville, AR

                                    Department of Biological Sciences

                                   

PROFESSIONAL SOCIETIES

 

American Society of Hematology (ASH)

 

American Society of Clinical Oncology (ASCO)

 

 

HONORS AND AWARDS

 

2008-2009                   Knights Templar Eye Foundation, Inc.  Pediatric Ophthalmology Research Grant.

 

2008-2009                   International Retinal Research Foundation, Inc.  Alston Callahan, MD Postdoctoral Scholar. 

 

2004                            Cora Verhagen Award, 1st Prize, Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).

 

2004                            Travel Grant, National Eye Institute, Annual Meeting of the Association for Research in Vision and Ophthalmology. 

 

 

BIBLIOGRAPHY

 

1.              Schimel AM, Abraham L, Cox D, Sene A, Kraus C, Dace DS, Ercal N, and Apte RS. 2011. N-acetylcysteine amide (NACA) prevents retinal degeneration by up-regulating reduced glutathione production and reversing lipid peroxidation. Am J Pathol. 178(5): 2032-2043.

 

2.              Khan AA, Dace DS, Ryazanov AG, Kelly J, and Apte RS. 2010. Resveratrol Regulates Pathologic Angiogenesis by a Eukaryotic Elongation Factor-2 Kinase-Regulated Pathway. Am J Pathol. 177(1): 481-492.

 

3.              Dace DS, Khan AA, Stark JL, Kelly J, Cross AH, and Apte RS.  2009. Interleukin-10 Overexpression Promotes Fas-Ligand-Dependent Chronic Macrophage-Mediated Demyelinating Polyneuropathy. PLoS One. 4(9): e7121.

 

4.              Dace DS, Khan AA, Kelly J, and Apte RS.  2008.  Interleukin-10 Regulates Pathological Developmental Angiogenesis by Regulating Macrophage Responsiveness to Hypoxia.  PLoS One.  3(10): e3381.

 

5.              Dace DS, Chen PW, and Niederkorn JY.  2008.  CD4+ T Cell-Dependent Tumor Rejection in an Immune Privileged Environment Requires Macrophages.  Immunology.  123: 367-377.

 

6.              Dace DS, Chen PW, and Niederkorn JY.  2007.  CD8+ T cells Circumvent Immune Privilege in the Eye and Mediate Intraocular Tumor Rejection by a TNF-a-Dependent Mechanism.  Journal of Immunology.  178: 6115-6122.

 

7.              Dace DS, Chen PW, Alizadeh H, and Niederkorn JY.  2007.  Ocular Immune Privilege is Circumvented by CD4+ T cells, Leading to the Rejection of Intraocular Tumors in an IFN-g Dependent Manner.  Journal of Leukocyte Biology. 81: 421-429.